Author: Moustafa Taalab

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.’s Chief Executive Officer, Dr. Amr Morsy, recognized among the top 100 Arabian CEOs of 2020

13:46 27 January in news by Moustafa Taalab

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E., (together with its consolidated subsidiaries, “Rameda”) with ticker name RMDA.CA on EGX, a leading Egyptian pharmaceutical company, announces today that its Chief Executive Officer (CEO), Dr. Amr Morsy, has been named as one of...

Read More

Rameda notified of Anviziram, Remdesivir-Rameda vial prices by Egyptian Drug Authority, on track to market first Remdesivir-Rameda production in September 2020

13:24 20 July in news by Moustafa Taalab

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents SAE (Rameda), RMDA.CA on the EGX, a leading Egyptian pharmaceutical company, announced today that it has been notified by the Egyptian Drug Authority of the public price for its product “Anviziram.” Anviziram, which contains the active...

Read More

Rameda commences manufacture of “Anviziram” Tablets the Generic Equivalent of Japanese antiviral Avigan for treatment of Covid-19 patients and receives approval from Egyptian Drug Authority to manufacture Remedsivir

10:02 22 June in news by Moustafa Taalab

Rameda, a leading Egyptian pharmaceutical company, announced today that it has commenced the manufacture of Anviziram. Anviziram contains the active pharmaceutical ingredient Favipiravir, which is the generic form of the antiviral sold under the brand name Avigan in Japan. Rameda has also secured approval from...

Read More

Rameda launches initiative for the complementary dispensary and home delivery of medication at no cost, underlining its dedication to ensuring the healthcare and safety among Egypt’s most immune-compromised patient populations amid the COVID-19 pandemic

10:20 26 April in news by Moustafa Taalab

Rameda, is pleased to announces today the launch of Rameda’s SPP (“Save Yourself, Stay Home, Protect your Family, Protect your Community”) project, aimed at reducing elderly and patients with special needs’ risk of exposure to COVID-19 through the electronic dispensary and home delivery of cardiovascular,...

Read More